...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New version of May slide deck and ERA-EDTA Conference & Symposium

BDAZ - I read the publication SP436 over a couple of times and wondered whether it was just the patients in the CKD sub study with eGFR <60 that would go out to 36 months or if it would be all patients in the BETonMACE trial that would participate up to 36 months. Do you have any thoughts on this?

tada

Share
New Message
Please login to post a reply